PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
L&G Healthcare Breakthrough UCITS ETF (DOCG.L)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINIE00BK5BC677
IssuerLegal & General
Inception DateJun 26, 2019
CategoryHealth & Biotech Equities
Index TrackedMSCI World/Health Care NR USD
Asset ClassEquity

Expense Ratio

DOCG.L has a high expense ratio of 0.49%, indicating higher-than-average management fees.


Expense ratio chart for DOCG.L: current value at 0.49% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.49%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


L&G Healthcare Breakthrough UCITS ETF

Popular comparisons: DOCG.L vs. VBR, DOCG.L vs. SWDA.L

Performance

Performance Chart

The chart shows the growth of an initial investment of £10,000 in L&G Healthcare Breakthrough UCITS ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%December2024FebruaryMarchAprilMay
9.52%
73.26%
DOCG.L (L&G Healthcare Breakthrough UCITS ETF)
Benchmark (^GSPC)

S&P 500

Returns By Period

L&G Healthcare Breakthrough UCITS ETF had a return of -3.81% year-to-date (YTD) and -10.32% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-3.81%8.61%
1 month-1.70%-0.45%
6 months12.40%18.66%
1 year-10.32%25.25%
5 years (annualized)N/A12.50%
10 years (annualized)N/A10.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-2.81%2.31%1.20%-6.06%
2023-11.28%7.49%12.66%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DOCG.L is 9, indicating that it is in the bottom 9% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of DOCG.L is 99
L&G Healthcare Breakthrough UCITS ETF(DOCG.L)
The Sharpe Ratio Rank of DOCG.L is 99Sharpe Ratio Rank
The Sortino Ratio Rank of DOCG.L is 1212Sortino Ratio Rank
The Omega Ratio Rank of DOCG.L is 1212Omega Ratio Rank
The Calmar Ratio Rank of DOCG.L is 55Calmar Ratio Rank
The Martin Ratio Rank of DOCG.L is 66Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF (DOCG.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


DOCG.L
Sharpe ratio
The chart of Sharpe ratio for DOCG.L, currently valued at -0.21, compared to the broader market0.002.004.00-0.21
Sortino ratio
The chart of Sortino ratio for DOCG.L, currently valued at 0.02, compared to the broader market-2.000.002.004.006.008.000.02
Omega ratio
The chart of Omega ratio for DOCG.L, currently valued at 1.00, compared to the broader market0.501.001.502.002.501.00
Calmar ratio
The chart of Calmar ratio for DOCG.L, currently valued at -0.20, compared to the broader market0.002.004.006.008.0010.0012.0014.00-0.20
Martin ratio
The chart of Martin ratio for DOCG.L, currently valued at -0.71, compared to the broader market0.0020.0040.0060.0080.00-0.71
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.36, compared to the broader market0.002.004.002.36
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.36, compared to the broader market-2.000.002.004.006.008.003.36
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.002.501.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.93, compared to the broader market0.002.004.006.008.0010.0012.0014.001.93
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.14, compared to the broader market0.0020.0040.0060.0080.009.14

Sharpe Ratio

The current L&G Healthcare Breakthrough UCITS ETF Sharpe ratio is -0.21. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of L&G Healthcare Breakthrough UCITS ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.00December2024FebruaryMarchAprilMay
-0.21
1.86
DOCG.L (L&G Healthcare Breakthrough UCITS ETF)
Benchmark (^GSPC)

Dividends

Dividend History


L&G Healthcare Breakthrough UCITS ETF doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-42.45%
-1.82%
DOCG.L (L&G Healthcare Breakthrough UCITS ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the L&G Healthcare Breakthrough UCITS ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the L&G Healthcare Breakthrough UCITS ETF was 51.45%, occurring on Oct 30, 2023. The portfolio has not yet recovered.

The current L&G Healthcare Breakthrough UCITS ETF drawdown is 42.45%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-51.45%Feb 16, 2021680Oct 30, 2023
-22.77%Feb 20, 202018Mar 16, 202028Apr 27, 202046
-13.03%Aug 2, 201957Oct 22, 201957Jan 15, 2020114
-7.75%Jul 24, 202030Sep 4, 20207Sep 15, 202037
-6.21%Oct 15, 202013Nov 2, 20205Nov 9, 202018

Volatility

Volatility Chart

The current L&G Healthcare Breakthrough UCITS ETF volatility is 5.67%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2024FebruaryMarchAprilMay
5.67%
4.67%
DOCG.L (L&G Healthcare Breakthrough UCITS ETF)
Benchmark (^GSPC)